Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians.

OBJECTIVE To test whether beta carotene supplementation affects the incidence of age-related maculopathy (ARM) in a large-scale randomized trial. DESIGN Randomized, double-masked, placebo-controlled trial among 22 071 apparently healthy US male physicians aged 40 to 84 years. Participants were randomly assigned to receive beta carotene (50 mg every other day) or placebo. Main Outcome Measure Incident ARM responsible for a reduction in best-corrected visual acuity to 20/30 or worse. RESULTS After 12 years of treatment and follow-up, there were 162 cases of ARM in the beta carotene group vs 170 cases in the placebo group (relative risk [RR], 0.96; 95% confidence interval [CI], 0.78-1.20). The results were similar for the secondary end points of ARM with or without vision loss (275 vs 274 cases; RR, 1.01; 95% CI, 0.86-1.20) and advanced ARM (63 vs 66 cases; RR, 0.97; 95% CI, 0.69-1.37). CONCLUSIONS These randomized data relative to 12 years of treatment among a large population of apparently healthy men indicate that beta carotene supplementation has no beneficial or harmful effect on the incidence of ARM. Long-term supplemental use of beta carotene neither decreases nor increases the risk of ARM.

[1]  R. Bone,et al.  Lutein, zeaxanthin, and the macular pigment. , 2001, Archives of biochemistry and biophysics.

[2]  Neil M Bressler,et al.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.

[3]  Michael M Lieber,et al.  Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2005, Journal of the National Cancer Institute.

[4]  F. Ferris,et al.  Antioxidants and zinc to prevent progression of age-related macular degeneration. , 2001, JAMA.

[5]  Nea Malila,et al.  Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. , 2003, JAMA.

[6]  C. Hennekens,et al.  Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. , 2000, Annals of epidemiology.

[7]  T. G. Truscott,et al.  β‐Carotene with vitamins E and C offers synergistic cell protection against NOx , 1998, FEBS letters.

[8]  S. Satterfield,et al.  Biochemical markers of compliance in the Physicians' Health Study. , 1990, American journal of preventive medicine.

[9]  R. Bone,et al.  Analysis of the macular pigment by HPLC: retinal distribution and age study. , 1988, Investigative ophthalmology & visual science.

[10]  M. Karagas,et al.  Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation , 1996 .

[11]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[12]  P. Rosenfeld,et al.  Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. , 2005, Ophthalmology.

[13]  E. Dratz,et al.  Carotenoids in the human macula and whole retina. , 1988, Investigative ophthalmology & visual science.

[14]  C. Hennekens,et al.  Carotenoid and tocopherol concentrations in plasma, peripheral blood mononuclear cells, and red blood cells after long-term beta-carotene supplementation in men. , 1996, The American journal of clinical nutrition.

[15]  R. Klein,et al.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[16]  Susan E Hankinson,et al.  The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. , 2002, The Journal of nutrition.

[17]  R. Hogg,et al.  AMD and micronutrient antioxidants , 2004, Current eye research.

[18]  A. Young,et al.  Antioxidant and prooxidant properties of carotenoids. , 2001, Archives of biochemistry and biophysics.

[19]  G. Omenn,et al.  The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. , 2004, Journal of the National Cancer Institute.

[20]  J. Manson,et al.  Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial , 2005, JAMA.

[21]  L. Jampol.  AREDS--two years later. , 2003, Archives of ophthalmology.

[22]  F. Khachik,et al.  Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. , 2001, Experimental eye research.

[23]  S. Bressler,et al.  Are antioxidants or other supplements protective for age-related macular degeneration? , 1996, Current opinion in ophthalmology.

[24]  E. Gragoudas,et al.  Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.

[25]  D. Albanes,et al.  Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. , 1998, Acta ophthalmologica Scandinavica.

[26]  J. Blumberg,et al.  The Potential Role of Dietary Xanthophylls in Cataract and Age-Related Macular Degeneration , 2000, Journal of the American College of Nutrition.

[27]  E. Niki,et al.  Interaction among vitamin C, vitamin E, and beta-carotene. , 1995, The American journal of clinical nutrition.

[28]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[29]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[30]  J. Manson,et al.  β-Carotene Supplementation and Incidence of Cancer and Cardiovascular Disease: the Women's Health Study. , 1999, Journal of the National Cancer Institute.

[31]  J. Manson,et al.  A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group. , 1995, Annals of epidemiology.